Ä¿¹Â´ÏƼ

¾¾¾ÆÀ̹ÙÀÌ¿À´Â ¹ÏÀ½°ú ½Å·Ú¸¦ ¹ÙÅÁÀ¸·Î
±Í»çÀÇ ±¹³», ÇØ¿ÜÁøÃâÀÇ ÆÄÆ®³Ê°¡ µÇ°Ú½À´Ï´Ù.

Ä¿¹Â´ÏƼ

  • Ȩ
  • Ä¿¹Â´ÏƼ
  • ÀÚ·á½Ç

ÀÚ·á½Ç

Á¦¸ñ identification of unknown impurities, QC/batch release, etc
ÀÛ¼ºÀÚ °ü¸®ÀÚ
ÀÛ¼ºÀÏÀÚ 2022-11-11
Á¶È¸¼ö 83
 regulatory ,pre-clinical, clinical trials, registration ±îÁö drug testing,(pre)clinical service,
  drug development µî ±¹³»¿Ü ±âÁØ¿¡ ¸ÂÃç ÇÁ·ÎÁ§Æ®¿¡ ¸Â°Ô ´Ù¾çÇÑ ¼­ºñ½º¸¦  Á¦°øÇÕ´Ï´Ù.


For example,
Identification of unknown impurities, QC/batch release, transfer method
 
÷ºÎÆÄÀÏ